Tag: CBD markets
-
The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than you’re borrowing but, in a down market, you’re under extra pressure to keep things together when debts come due.”
-
Nextleaf (OILS.C) cuts a deal with an Ontario cannabis grower
OIL’s CEO, Paul Pedersen, believes the key to a strong sustainable cannabis extraction business is innovative technology protected by international patents.
-
1933 Industries (TGIF.C) scrambles to keep up with increased Nevada cannabis demand
Last week, Nevada Governor Steve Sisolak allowed the shops to continue at-home deliveries because marijuana is considered an “essential business”, reported The Reno Gazette, “Much like the grocery stores trying to fill orders for rice and potatoes, cannabis retailers cannot fill marijuana delivery orders fast enough.”
-
Hemptown USA CEO Eric Gripentrog gives a pre-IPO update
We are currently primarily focused on wholesale, selling bulk products. Quickly, we will be pivoting to the $16 billion dollar industry which breaks out between nutraceuticals, beauty aids, food and beverages.
-
1933 Industries (TGIF.C) is getting bigger, bolder, more badass
On January 22, 2020 1933 Industries (TGIF.C) gave the market an update on its bulk hemp processing facility in Las Vegas, USA. The facility will be capable of producing isolated cannabinoids such as CBD, CBG, CBC and CBN, as well as full spectrum and broad-spectrum oils without THC. The proprietary extraction system will reduce industry-standard…
-
Pivot Pharma (PVOT.C): can a new CEO turn a cannabis science co. into a profit machine?
Perusing Pivot Pharmaceuticals’ (PVOT.C) website you might think you’ve stumbled onto Pfizer’s (PFE.NYSE) “Proprietary IP” link. “RTIC infused substrates”? “Supercritical extraction”? “Phospholipid bilayers”? Anyone? In fact, if you strip away the tech-talk – Pivot’s business model is not that hard to wrap your head around. Pivot is a “science-based medical wellness company” that has developed…
-
Hemptown buys FDA-approved plant with $6 mil/year existing revenue
I once consulted with a veteran CEO (potash, lithium, tech, gold) who told me, “Before I take a company public, I’ve got 60 press releases written in my head”. Since the man had created over $1 billion in enterprise value, I wasn’t going to argue with his roll-out template. His idea: you don’t take a…